{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:06:23Z","timestamp":1770746783343,"version":"3.49.0"},"reference-count":52,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T00:00:00Z","timestamp":1401148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>New vaccines targeting meningococci expressing serogroup B polysaccharide have been developed, with some being licensed in Europe. Coverage depends on the distribution of disease-associated genotypes, which may vary by age. It is well established that a small number of hyperinvasive lineages account for most disease, and these lineages are associated with particular antigens, including vaccine candidates. A collection of 4,048 representative meningococcal disease isolates from 18 European countries, collected over a 3-year period, were characterized by multilocus sequence typing (MLST). Age data were available for 3,147 isolates. The proportions of hyperinvasive lineages, identified as particular clonal complexes (ccs) by MLST, differed among age groups. Subjects &lt;1 year of age experienced lower risk of sequence type 11 (ST-11) cc, ST-32 cc, and ST-269 cc disease and higher risk of disease due to unassigned STs, 1- to 4-year-olds experienced lower risk of ST-11 cc and ST-32 cc disease, 5- to 14-year-olds were less likely to experience ST-11 cc and ST-269 cc disease, and \u226525-year-olds were more likely to experience disease due to less common ccs and unassigned STs. Younger and older subjects were vulnerable to a more diverse set of genotypes, indicating the more clonal nature of genotypes affecting adolescents and young adults. Knowledge of temporal and spatial diversity and the dynamics of meningococcal populations is essential for disease control by vaccines, as coverage is lineage specific. The nonrandom age distribution of hyperinvasive lineages has consequences for the design and implementation of vaccines, as different variants, or perhaps targets, may be required for different age groups.<\/jats:p>","DOI":"10.1128\/cvi.00133-14","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T06:22:34Z","timestamp":1396506154000},"page":"847-853","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development"],"prefix":"10.1128","volume":"21","author":[{"given":"Carina","family":"Brehony","sequence":"first","affiliation":[{"name":"Department of Zoology, University of Oxford, Oxford, United Kingdom"}]},{"given":"Caroline L.","family":"Trotter","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}]},{"given":"Manosree","family":"Chandra","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}]},{"given":"Keith A.","family":"Jolley","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Oxford, Oxford, United Kingdom"}]},{"given":"Arie","family":"van der Ende","sequence":"additional","affiliation":[{"name":"The Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Centre, Department of Medical Microbiology, Amsterdam, Netherlands"}]},{"given":"Fran\u00e7oise","family":"Carion","sequence":"additional","affiliation":[{"name":"Meningococcal Reference Laboratory, Scientific Institute of Public Health, Brussels, Belgium"}]},{"given":"Lene","family":"Berthelsen","sequence":"additional","affiliation":[{"name":"Neisseria and Streptococcus Reference Laboratory, Statens Serum Institut, Copenhagen, Denmark"}]},{"given":"Steen","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Neisseria and Streptococcus Reference Laboratory, Statens Serum Institut, Copenhagen, Denmark"}]},{"given":"Hj\u00f6rd\u00eds","family":"Har\u00f0ard\u00f3ttir","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Landspitali University Hospital, Reykjavik, Iceland"}]},{"given":"Julio A.","family":"Vazquez","sequence":"additional","affiliation":[{"name":"Meningococcal Reference Laboratory, Madrid, Spain"}]},{"given":"Karen","family":"Murphy","sequence":"additional","affiliation":[{"name":"Irish Meningococcal and Meningitis Reference Laboratory, Dublin, Ireland"}]},{"given":"Maija","family":"Toropainen","sequence":"additional","affiliation":[{"name":"National Institute for Health and Welfare, Helsinki, Finland"}]},{"given":"Manuela","family":"Cani\u00e7a","sequence":"additional","affiliation":[{"name":"Laboratory of Antimicrobial Resistance, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal"}]},{"given":"Eugenia","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laboratory of Antimicrobial Resistance, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal"}]},{"given":"Mathew","family":"Diggle","sequence":"additional","affiliation":[{"name":"The Scottish Haemophilus, Legionella, Meningococcus, and Pneumococcus Reference Laboratory, Glasgow, United Kingdom"}]},{"given":"Giles F.","family":"Edwards","sequence":"additional","affiliation":[{"name":"The Scottish Haemophilus, Legionella, Meningococcus, and Pneumococcus Reference Laboratory, Glasgow, United Kingdom"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[{"name":"National Reference Centre for Meningococci, Pasteur Institute, Paris, France"}]},{"given":"Paola","family":"Stefanelli","sequence":"additional","affiliation":[{"name":"Department of Infectious, Parasitic, and Immune-Mediated Diseases, Istituto Superiore di Sanit\u00e0, Rome, Italy"}]},{"given":"Paula","family":"Kriz","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for Meningococcal Infections, National Institute of Public Health, Prague, Czech Republic"}]},{"given":"Steve J.","family":"Gray","sequence":"additional","affiliation":[{"name":"Meningococcal Reference Unit, Manchester Royal Infirmary, Manchester, United Kingdom"}]},{"given":"Andrew J.","family":"Fox","sequence":"additional","affiliation":[{"name":"Meningococcal Reference Unit, Manchester Royal Infirmary, Manchester, United Kingdom"}]},{"given":"Susanne","family":"Jacobsson","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Clinical Microbiology, \u00d6rebro University Hospital, \u00d6rebro, Sweden"}]},{"given":"Heike","family":"Claus","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Hygiene und Mikrobiologie, W\u00fcrzburg, Germany"}]},{"given":"Ulrich","family":"Vogel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Hygiene und Mikrobiologie, W\u00fcrzburg, Germany"}]},{"given":"Georgina","family":"Tzanakaki","sequence":"additional","affiliation":[{"name":"National Meningococcal Reference Laboratory, National School of Public Health, Athens, Greece"}]},{"given":"Sigrid","family":"Heuberger","sequence":"additional","affiliation":[{"name":"National Reference Centre for Meningococci, Institute for Medical Microbiology and Hygiene, Graz, Austria"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"}]},{"given":"Matthias","family":"Frosch","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Hygiene und Mikrobiologie, W\u00fcrzburg, Germany"}]},{"given":"Martin C. J.","family":"Maiden","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Oxford, Oxford, United Kingdom"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61016-2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70048-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.032"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.Supplement_A.25"},{"key":"e_1_3_2_6_2","volume-title":"Meningococcal disease","author":"Cartwright K","year":"1995","unstructured":"CartwrightK (ed). 1995. Meningococcal disease. John Wiley & Sons, Chichester, United Kingdom."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-8993-2_5"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.2.323-330.1994"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/428351"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/428590"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00091-09"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1904.111799"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.063"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046019"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182706b89"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044102"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3201\/eid1003.020611","article-title":"Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland","volume":"10","author":"McEllistrem MC","year":"2004","unstructured":"McEllistremMCKolanoJAPassMACaugantDAMendelsohnABFonseca PachecoAGShuttKARazeqJHarrisonLHMaryland Emerging Infections Program. 2004. Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg. Infect. Dis. 10:451\u2013456.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/501371"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1801.110901"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.21794"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.2900\/76137"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.033"},{"key":"e_1_3_2_24_2","first-page":"125","article-title":"Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway","volume":"14","author":"Bjune G","year":"1991","unstructured":"BjuneGGronnesbyJKH\u00f8ibyEAClossONoklebyH. 1991. Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway. NIPH Ann. 14:125\u2013130.","journal-title":"NIPH Ann."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70027-5"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2006.00056.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.12.4492-4498.2000"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.6.3140"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02900361"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2006.00060.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.26.11.2465-2466.1988"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.11.4190-4192.2001"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-06"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.062"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065043"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00027-10"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70006-9"},{"key":"e_1_3_2_38_2","volume-title":"Invasive Neisseria meningitidis in Europe 2006","author":"EU-IBIS Network","year":"2007","unstructured":"EU-IBIS Network. 2007. Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency, London, United Kingdom."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/315158"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.09.008"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06835-11"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071943"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003885"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/137.2.112"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.4.2424-2432.2005"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1998.tb01379.x"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045349"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.11.5146-5153.2004"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.2807\/ese.16.23.19885-en"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05385-11"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.2807\/ese.14.16.19179-en"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1709.101762"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-595"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00133-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00133-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:18:29Z","timestamp":1746170309000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00133-14"}},"subtitle":[],"editor":[{"given":"M. F.","family":"Pasetti","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1128\/CVI.00133-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00133-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"2014-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-03-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}